CliffBio
small molecule

NASACORT

TRIAMCINOLONE ACETONIDE

Loss of exclusivity—loss of exclusivity
CompanyCHATTEM INC DBA SANOFI CONSUMER HEALTHCARE

Drug detail

Brand nameNASACORT
Active ingredientTRIAMCINOLONE ACETONIDE
Strength0.055MG/INH
Dosage formAEROSOL, METERED
RouteNASAL
ModalitySmall molecule
FDA approvalJuly 1991
Marketing statusDISCN

More from CHATTEM INC DBA SANOFI CONSUMER HEALTHCARE

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

NASACORT patent cliff — loss of exclusivity — | CliffBio